Neuroscience

SARS-CoV-2 vaccine does not increase new-onset seizure risk

There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus placebo, according to a review published online April 29 in JAMA Neurology.

Diseases, Conditions, Syndromes

Race, racism, and COVID-19 in the US: Lessons to be learned

In a publication in The BMJ, Keisha Bentley-Edwards at Duke University, North Carolina, and colleagues argue that systemic racism and economic inequality are at the root of disparity in COVID-19 outcomes and suggest ways ...

Oncology & Cancer

Hitchhiking cancer vaccine makes progress in the clinic

Therapeutic cancer vaccines are an appealing strategy for treating malignancies. In theory, when a patient is injected with peptide antigens—protein fragments from mutant proteins only expressed by tumor cells—T cells ...

page 1 from 40